Design
BLIND
This was a double blind, placebo‐controlled, randomized, crossover study. After completing an initial visit (described below), participants were randomly assigned to either BET or a noncaloric placebo (PLA) supplemental condition. Participants consumed 50 mg·kgStudy outline.